Abstract:To combat the fast-moving spread of the pandemic we need an equally speedy and powerful tool. On the forefront against COVID-19, for example, AI technology has become a digital armament in the development of new drugs, vaccines, diagnostic methods, and forecasting programs. Patenting these new, nonobvious, and efficient technological solutions is a critical step in fostering the research and development, the huge investments as well as the commercial processes. This article considers the challenges of the current patent law as they apply to AI inventions in general and especially in the age of a global pandemic. The article proposes a novel solution to the hurdles of patenting AI technology by establishing a new patent track model for AI inventions (including the inventions that are made by AI systems and creative AI systems themselves). Unlike other publications promoting either complete abandonment of AI related patents, or advocating to maintain current patent laws, or recommending minor adjustment to patent laws, this article suggests a novel model of separate patent venue solely targeting AI inventions. The argument of this article is based on four pillars: the difficulty of having a patent-eligible subject matter, the hurdle of the "blackbox" conundrum, the confusion of who is "a person of ordinary skills in the art" ("POSITA"), and the criticality of establishing a new AI patent track model, a crucial step, especially during a global epidemic. The first pillar of the argument is the difficulty of having a patent-eligible subject matter in AI inventions. We therefore propose the new AI patent track model that would extend the scope of patent protection to cover creative AI systems, including both the algorithms and trained models, and AI-made inventions in order to, inter alia, incentivize investments of the "Multi-Players". The second pillar of the argument of the argument is the hurdle posed by the "blackbox" conundrum of AI systems that undermines the explainability and transparency of the inventions. In analogy to already existing rules applied to microorganism patents that are hard to describe, we advise a depository rule for AI working models to sufficiently describe the otherwise inexplicable inventions. The third pillar arises from the confusion of who is a person of ordinary skills in regard to the nonobviousness assessment of AI inventions. We submit an alternative standard of "a skilled person using an ordinary AI tool in the art" under the new track model to enable the evaluation of the patentability of complex AI inventions. The fourth pillar of the argument is the criticality of establishing a new AI patent track model on the grounds that the current patent law regime has posed substantial hurdles and uncertainties for patenting AI inventions with regard to almost all patentability requirements. We analyzed each of the requirements to demonstrate that most, if not all, aspects of patent law are not suitable in the AI era; only a revolutionary new patent model specific for AI inventions could solve all the concerns while maintaining the patent incentive for innovations. Our model also suggests an expedited examination with the aid of AI tools and a shortened patent lifetime in light of the fast AI development and technology elimination speed. The article concludes with the hope to harness AI technology for the wellbeing of humanity, in general and especially during tough times in the current COVID-19 era and in general.

Pandemic-Resilient Investment: Sustainable Knowledge Infrastructure for Medical AI

Tackling COVID-19 through responsible AI innovation: Five steps in the right direction

Evolving intellectual property landscape for AI-driven innovations in the biomedical sector: opportunities in stable IP regime for shared success

Summoning a New Artificial Intelligence Patent Model: In The Age Of Pandemic

Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements

Democratising artificial intelligence in healthcare: community-driven approaches for ethical solutions

The advancement of artificial intelligence in biomedical research and health innovation: challenges and opportunities in emerging economies

Distributed Governance of Medical AI

Promoting innovation in mental health treatment: Exploring intellectual property laws in innovative and affordable technologies

The Future of Artificial Intelligence in International Healthcare: An Index

Open source approaches for pediatric global health technologies

Opportunities and challenges for innovative and equitable healthcare

Precision medicine: affording the successes of science

Designing AI‐augmented healthcare delivery systems for physician buy‐in and patient acceptance

AI and the Art of Healing: Cultural Perspectives on Healthcare Innovation

Fortifying Health Care Intellectual Property Transactions With Blockchain

Artificial Intelligence as a Potential Catalyst to a More Equitable Cancer Care

Intellectual Property Rights and Access in Crisis

Creating Knowledge Assets under Biocapitalism: Analyzing China's Biomedical Industry and Its Patent Networks

Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?

A powerful potion for a potent problem: transformative justice for generative AI in healthcare